New trial aims to slash deadly complications in Kids' stem cell transplants
NCT ID NCT07679100
First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time
Summary
This trial tests multiple new treatments to improve outcomes for children receiving a stem cell transplant. It includes children from 1 week to 18 years old who are getting a transplant. The goal is to reduce serious complications like organ failure and infections, and make transplants safer and more effective.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- multiple interventions (to be added over time)
- What this could lead to
- If successful, this trial could identify better ways to manage stem cell transplants in children, reducing severe complications and improving survival and quality of life.
- What could go wrong
- This is an early-stage platform trial testing many interventions; results may take years and some interventions may prove ineffective or have unexpected side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HAEMATOPOIETIC STEM CELL TRANSPLANT, ALLOGENEIC are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.